Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Concise Method
2.3. Testing of Antimicrobial Susceptibility
Ask a
question
Favorite
The susceptibility profiles were generated using Kirby–Bauer disc diffusion assays, following Clinical & Laboratory Standards Institute (CLSI) guidelines (CLSI, 2017), and the antibiotics tested were aminoglycosides (amikacin (30 μg), gentamicin, (10 μg)), carbapenem (meropenem, (10 μg)), third generation cephalosporin (cefotaxime, (30 μg)), fluoroquinolone (ciprofloxacin, (5 μg)), penicillin+β-lactamase inhibitor (piperacillin/tazobactam, (100/10 μg)), and phenicol (chloramphenicol, (30 μg)) (Himedia labs).
Copyright and License information: ©2020 by the authors.
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
